Senores Pharmaceuticals (NSE:SENORES) FCF Margin %: 0.00% (As of Mar. 2026)


NSE:SENORES Senores Pharmaceuticals Ltd NSE:SENORES
18 GF Score
Price ₹1,269.70
! 7 Warning Signs
View Full Analysis

What is Senores Pharmaceuticals FCF Margin %?

Senores Pharmaceuticals NSE:SENORES -0.39% 18 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:SENORES with a GF Score™ of 18/100. The stock has 7 warning signs investors should review. Among 955 Drug Manufacturers companies, Senores Pharmaceuticals ranks worse than 86.39% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Senores Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was ₹0 Mil. Senores Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was ₹1,752 Mil. Therefore, Senores Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Senores Pharmaceuticals's current FCF Yield % is -3.47%.

The historical rank and industry rank for Senores Pharmaceuticals's FCF Margin % or its related term are showing as below:

NSE:SENORES' s FCF Margin % Range Over the Past 10 Years
Min: -150.19   Med: -51.08   Max: -32.04
Current: -32.5

During the past 5 years, the highest FCF Margin % of Senores Pharmaceuticals was -32.04%. The lowest was -150.19%. And the median was -51.08%.

NSE:SENORES's FCF Margin % is ranked worse than
86.39% of 955 companies
in the Drug Manufacturers industry
Industry Median: 2.51 vs NSE:SENORES: -32.50

Senores Pharmaceuticals FCF Margin % Related Terms

Senores Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Senores Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senores Pharmaceuticals FCF Margin % Chart

Senores Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
-150.19 -136.89 -36.78 -51.08 -32.04

Senores Pharmaceuticals Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:SENORES vs LLY, JNJ, ABBV: FCF Margin % Comparison

For the Drug Manufacturers - General subindustry, Senores Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Senores Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Senores Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Senores Pharmaceuticals's FCF Margin % falls into.


NSE:SENORES
18GF Score
Senores Pharmaceuticals Ltd NSE:SENORES
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senores Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Senores Pharmaceuticals's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-2026.8/6326.3
=-32.04 %

Senores Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/1751.9
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Senores Pharmaceuticals (NSE:SENORES) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Senores Pharmaceuticals and its competitors. According to the industry distribution chart, Senores Pharmaceuticals ranks #825 out of 955 companies in the Drug Manufacturers industry, placing it in the top 86.4%.
Is Senores Pharmaceuticals' FCF Margin % too high?
Senores Pharmaceuticals' current FCF Margin % is 0.00%. Based on the distribution chart, Senores Pharmaceuticals ranks #825 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Senores Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Senores Pharmaceuticals' FCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Senores Pharmaceuticals ranks #825 out of 955 companies for FCF Margin %. This places Senores Pharmaceuticals in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Senores Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senores Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senores Pharmaceuticals stock overvalued right now?
Senores Pharmaceuticals (NSE:SENORES) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Senores Pharmaceuticals' overall GF Score™ is 18/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Senores Pharmaceuticals (NSE:SENORES), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Senores Pharmaceuticals Business Description

Other Exchanges 544319:India
Address Ambali Bopal Road, 1101 to 1103, 11th floor, South Tower, ONE 42, Opposite Jayantilal Park, Ahmedabad, GJ, IND, 380054
Senores Pharmaceuticals Ltd is a research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of the USA, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Its strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing the company as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, It strategically identifies commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets.
18GF Score

Get the complete analysis for NSE:SENORES

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,269.70
Price